1Ahn JK, Seo JM, Yu J,et al. Down-regulation of IFN-gamma-producing CD56^+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behcet's uveitis[J].Invest Ophthalmol Vis Sci, 2005 ,46:2458-2464. 被引量：1
2Angunawela RI, Heatley C J, Williamson TH, et al. Inteavitreal triamcinalone acetonide for refractory uveitc cystoid macular oedema: longterm management and outcome[J]. Acta Ophthalmol Scand, 2005, 83:595-599. 被引量：1
3de Vos AF, Vafl Haren M A, Verhagen C, et al.Systemic anti-tumor necrosis factor an tibody treatment exacerbates endotoxin. induced uveitis in therat[J]. Exp Eye Res, 1995, 61: 667-675. 被引量：1
4Foster CS. General principles and philosophy. In:Foster CS, Vital AT. Diagnosis and treatment of uveitis[J]. Philadelphia: W.B. Saunders Company,2002. 27-33. 被引量：1
5Hanlza M H. Treatment of Be hcet's disease with thalidomide[J]. Clin Rheumatol, 1986,5: 365-371. 被引量：1
6Hoey S, Grabowski PS, Ralston SH, et al. Nitric oxide accelerates the onset an d increases the seventy of experimental autoimmune uveoretinitis through an IFN-7-dependent mechanism[J]. J Immunol, 1997,159: 5132-5142. 被引量：1
7Ishikawa T, Hokama H, Katagiri Y, et al Effects of intravitreal injection of tacrolimus (FK506) in experimental uveitis[J]. Curr Eye Res, 2005, 30:93-101. 被引量：1
8Jonas JB, Kreissig I, Degenrmg R. Intraocular pressure after intravitreal injection of triamcinolone acetonide[J]. Br J Ophthalmol, 2003,87:24-27. 被引量：1
9Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular disease[J]. Prog Retina Eye Res, 2005, 24:587-611. 被引量：1
10Joseph A, Raj D, Dua HS, et al. Infliximab in the treatment of refractory posterior uveitis[J]. Ophthalmology, 2003, 110: 1449-1453. 被引量：1
二级参考文献38
1Nag CS, Rosenthal AR. Classification and epidemiology of uveitis.In: Easty DL, Sparrow JM, eds. Oxford textbook of ophthalmology.Oxford: Oxford university press, 1999. 509-516. 被引量：1
2Harper SL, Chorich LJ, Foster CS. Diagnosis of uveitis. In: Foster CS, Vital AT, eds. Diagnosis and treatment of uveitis.Philadelphia: WB Saunders Company, 2002.79-97. 被引量：1
3CunninghamET CrawfordJB In:Vaughan D Asburg T Riordan Eva P eds.Uveal tract and sclem[A].In:Vaughan D,Asburg T,Riordan Eva P,eds.General Ophthalmology[C].北京:人民卫生出版社,2001.142-158. 被引量：1
4Chang JHM, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm, 2002, 10:263-279. 被引量：1
5Merrill PT, Kim J, Cox TA, et al. Uveitis in the southeastern United States. Curt Eye Res, 1997, 16:865-874. 被引量：1
6Mercanti A, Parolini B, Bonora A, et al. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases.Acta Ophthalmol Scand, 2001, 79:64-68. 被引量：1
7Kotake S, Furudate N, Sasamoto Y, et al. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol, 1997, 235:5-9. 被引量：1
8Yang PZ, Chen L, Zwart R, et al. Immune cells in the porcine retina: Distribution, characterization, morphological features. Invest Ophthalmol Vis Sci, 2002, 43.. 1488-1492. 被引量：1
9Chen L, Yang PZ, Kijlstra A. Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamma, 2002,10: 27-39. 被引量：1
10Yang PZ, Das PK, Kijlstra A. Localization and characterization of immunocompetent ceils in the retina. Ocul Immunol Inflamma,2000, 8 : 149-157. 被引量：1
